Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Cho, Jeonghee

Class:IdPerson:1982011
_displayNameCho, Jeonghee
_timestamp2016-07-20 19:16:35
affiliation[Affiliation:1990846] Dana Farber Cancer Institute, Broad Institute
created[InstanceEdit:1982010] Rothfels, K, 2011-11-09
firstnameJeonghee
initialJ
modified[InstanceEdit:1990847] Orlic-Milacic, Marija, 2011-11-14
[InstanceEdit:8932050] D'Eustachio, Peter, 2016-07-20
surnameCho
(author)[LiteratureReference:1982030] Inhibitor-Sensitive FGFR1 Amplification in Human Non-Small Cell Lung Cancer
[LiteratureReference:5687829] Tpl2 (tumor progression locus 2) phosphorylation at Thr290 is induced by lipopolysaccharide via an Ikappa-B Kinase-beta-dependent pathway and is required for Tpl2 activation by external signals
[LiteratureReference:6792531] Induction of COX-2 by LPS in macrophages is regulated by Tpl2-dependent CREB activation signals
[LiteratureReference:9665365] Functional analysis of receptor tyrosine kinase mutations in lung cancer identifies oncogenic extracellular domain mutations of ERBB2
[Change default viewing format]
No pathways have been reviewed or authored by Cho, Jeonghee (1982011)